Rule requiring drug prices in TV ads blocked by judge

A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked Monday by a federal judge.

The rule, meant to slow rising drug prices, would apply to any drug that costs more than $35 a month and was to take effect this week. Drug makers Merck, Eli Lilly, and Amgen sued in June to block the rule, The New York Times reported.

The Department of Health and Human Services exceeded its regulatory authority by trying to impose the requirement, Judge Amit P. Mehta, of U.S. District Court in the District of Columbia, ruled.

Source: Read Full Article

Related posts:
  1. Drug shortages: Limited warnings, followed by rationing and hoarding
  2. Some pharmacies thwart efforts to improve access to the opioid overdose reversal drug
  3. THC more important for therapeutic effects in cannabis than previously believed
  4. PBS restrictions result in outdated and unsafe care
  5. How black pharmacists are closing the cultural gap in health care